Ovid Therapeutics Inc — Financial Statements (NASDAQ:OVID) | MetaTrader

Open full chart

뉴스

PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates

Ovid Therapeutics: Bullish Post-PIPE With Two Differentiated CNS Moonshots

Ovid’s KCC2 activator shows promising safety in early trial

오비드 테라퓨틱스, 주식 수 증가 및 관련 제안 승인

Ovid Therapeutics shareholders approve increase in authorized shares and related proposals

오비드 테라퓨틱스, 뇌전증 치료제에 ’매수’ 등급

Roth/MKM initiates Ovid Therapeutics stock with Buy rating on epilepsy drug

Ovid Therapeutics, 최고 의학 책임자로 Petra Kaufmann 임명

Ovid Therapeutics appoints Petra Kaufmann as chief medical officer

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Adverum Biotechnologies (NASDAQ:ADVM), Alto Neuroscience (NYSE:ANRO)

Ovid Therapeutics Q3 실적, 수익 에상치보다 저조

Ovid Therapeutics earnings missed by $0.02, revenue fell short of estimates